BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
1.470
-0.040 (-2.65%)
At close: Mar 23, 2026, 4:00 PM EDT
1.485
+0.015 (1.02%)
Pre-market: Mar 24, 2026, 7:43 AM EDT
BioXcel Therapeutics Market Cap
BioXcel Therapeutics has a market cap or net worth of $32.15 million as of March 24, 2026. Its market cap has increased by 340.39% in one year.
Market Cap
32.15M
Enterprise Value
105.26M
1-Year Change
340.39%
Ranking
Category
Stock Price
$1.47
Market Cap Chart
Since March 8, 2018, BioXcel Therapeutics's market cap has decreased from $167.60M to $32.15M, a decrease of -80.82%. That is a compound annual growth rate of -18.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 33.00M | -5.71% |
| Dec 31, 2025 | 35.00M | 118.75% |
| Dec 31, 2024 | 16.00M | -81.48% |
| Dec 29, 2023 | 86.40M | -85.65% |
| Dec 30, 2022 | 601.90M | 5.82% |
| Dec 31, 2021 | 568.80M | -49.48% |
| Dec 31, 2020 | 1.13B | 327.25% |
| Dec 31, 2019 | 263.50M | 336.26% |
| Dec 31, 2018 | 60.40M | -63.96% |
| Mar 8, 2018 | 167.60M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Citius Oncology | 56.77M |
| Incannex Healthcare | 42.86M |
| Cumberland Pharmaceuticals | 42.33M |
| SCYNEXIS | 41.64M |
| Rockwell Medical | 41.38M |
| Talphera | 38.82M |
| InterCure | 36.49M |
| Zhengye Biotechnology Holding | 33.65M |